Non-specific tissue and fluid interface

Non-specific tissue and fluid interfaces refer to the physical boundaries between different biological phases, such as the air-liquid interface in the pulmonary alveoli or the gas-liquid interface in the digestive tract. Unlike traditional therapeutic targets like enzymes or receptors, these interfaces are not defined by a specific protein sequence but by their physical-chemical properties, including surface tension and viscosity (ChEMBL, 2024). Drugs that interact with these interfaces typically act through physical mechanisms; for example, pulmonary surfactants like poractant alfa reduce surface tension to prevent alveolar collapse in respiratory distress syndrome (StatPearls, 2023). Similarly, simethicone acts as an anti-foaming agent by altering the surface tension of gas bubbles in the gastrointestinal tract, allowing them to coalesce and be expelled more easily (PubChem, 2024). These interfaces are also critical in the ocular environment, where artificial tears stabilize the tear film to treat dry eye symptoms (StatPearls, 2024). Because the interaction is physical rather than biochemical, these targets do not exhibit traditional saturation kinetics or high molecular specificity. However, they are essential for maintaining the structural and functional integrity of organs that rely on fluid dynamics and surface stability.

Other names

Biological interfacePhysical interfaceTissue-fluid boundarySurface tension interfaceNon-specific tissue and fluid interfaces

Physical modification of surface tension, viscosity, or lubrication at biological boundaries to restore physiological function (StatPearls, 2023; PubChem, 2024).